News FDA probes blood cancer immunotherapy safety Regulator reviewing combination therapy safety after issue with Keytruda
Views & Analysis Evolving immunotherapy strategies in NSCLC Status of immunotherapies in non-small cell lung cancer (NSCLC).
News Clovis and BMS combine cancer drugs in late-stage trials Clovis and BMS research small molecule and antibody combination.
News Roche raises outlook for 2017 following strong launches The launch of three new products with blockbuster potential helped increase Roche’s revenues 5% in
News Europe recommends Tecentriq in bladder cancer, but efficacy ... The European Union’s CHMP committee recommended 11 medicines on Friday, including five orphan drugs.
Views & Analysis Immuno-oncology drugs: key to the Cancer Moonshot? Assessing the global challenges inhibiting immuno-oncology market access.
News Diagnostics lag is holding back new therapies, says study Advances in therapeutics are outpacing the development of diagnostics due to policy and payment barriers, holding back effective, targeted care.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
